Penn Engineers have developed an open-source algorithm that combines the speed of AI with the precision of geometry to ...

With $500 million in funding and a reported $2.5 billion valuation, Flourish wants to reinvent AI by putting real neurons ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Say goodbye to the Google search bar you’ve known for 25 years. The company is making it bigger and more interactive. The redesign is a response to AI, which has changed the way people search. Instead ...

For a quarter century, the Google search box has been one of the most recognizable interfaces in computing: a thin white rectangle, a blinking cursor, a few typed words, and a list of blue links. On ...

The era of the “ten blue links” is officially over. At its Google I/O conference on Tuesday, Google unveiled an AI-powered overhaul of Search centered around a reimagined “intelligent search box” — ...

Using a new Gemini A.I. model, the tech giant is overhauling its search box dimensions to answer longer queries, adding a video-generation tool and simplifying online shopping. By Tripp Mickle Kate ...

The S&P 500 and Nasdaq each set intraday records on Friday, but a majority of stocks were actually falling. The S&P 500 was up 0.7% after setting an intraday record at 7164.45. The Nasdaq was up 1.5% ...

What’s unusual today is the degree of divergence between individual stocks and the cap-weighted index. The single most damaging decision most investors make during periods of falling stock market ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...

Google's John Mueller said that when it comes to AI Search and the changes that come with that, Google's core search algorithms, spam detection methods, spam policies, and other search systems do not ...

(RTTNews) - Kymera Therapeutics, Inc. (KYMR) announced that the first patient has been dosed in its BREADTH Phase 2b clinical trial evaluating KT-621, an oral, highly selective degrader of STAT6, in ...